sur Protagonist Therapeutics, Inc. (NASDAQ:PTGX)
Protagonist Therapeutics Engages in Key Investment Conferences
Protagonist Therapeutics, a biopharmaceutical company based in Newark, California, will participate in several investment bank conferences in September 2025. Dinesh V. Patel, Ph.D., President and CEO, will represent the company in these events.
The company will engage in a fireside chat at Citi's 2025 Biopharma Back to School Summit in Boston on September 3 and at the H.C. Wainwright 27th Annual Global Investment Conference in New York on September 9. Protagonist will also participate in a panel about immunology at the BofA 11th Annual World Medical Innovation Forum in Boston on September 16.
Protagonist is advancing two peptides in Phase 3 clinical trials. Icotrokinra, in collaboration with J&J, and Rusfertide, developed with Takeda, are key focuses. Webcasts of these presentations will be accessible on the company's website for a year.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Protagonist Therapeutics, Inc.